A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice
Backgrounds and Objectives IMD‐0354 is a novel I kappa‐B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature‐induced periodontitis. Material and Methods We ligated around the upper right second molars of 8...
Gespeichert in:
Veröffentlicht in: | Journal of periodontal research 2019-04, Vol.54 (2), p.164-173 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 173 |
---|---|
container_issue | 2 |
container_start_page | 164 |
container_title | Journal of periodontal research |
container_volume | 54 |
creator | Kure, Keitetsu Sato, Hiroki Suzuki, Jun‐ichi Itai, Akiko Aoyama, Norio Izumi, Yuichi |
description | Backgrounds and Objectives
IMD‐0354 is a novel I kappa‐B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature‐induced periodontitis.
Material and Methods
We ligated around the upper right second molars of 8‐week‐old C57BL/6J mice in the split‐mouth model. The test mice were injected intraperitoneally with IMD‐0354 before the placement of the ligature. The control mice were injected intraperitoneally with 0.5% carboxymethylcellulose (CMC) as vehicle before the placement of the ligature. To determine the optimum concentration of the reagent on ligature‐induced periodontitis in the mice, we examined the effect of three types of concentration, which were 1, 5, and 10 mg/kg of IMD‐0354, as a preliminary experiment. After we determined 10 mg/kg as the optimum concentration for the IMD group by micro‐CT analysis, both the IMD and CMC groups (n = 15 each in total, including all the analyses) were subdivided into two small groups, respectively, for further analyses: I group (unligated side of IMD group), IL group (ligated side of IMD group), C group (unligated side of CMC group) and CL group (ligated side of CMC group). The mice in the IMD and CMC groups were treated with each reagent daily and sacrificed 8 days after the ligation. For assessment of bone resorption, we performed micro‐CT and histological analyses. We also carried out real‐time PCR to investigate proinflammatory and bone metabolic markers.
Results
There were significant differences for linear bone loss and volumetric parameter in the test (IMD) group compared to the control (CMC) group 8 days after ligation. In terms of the mRNA expression level of gingival tissue, the level of RANKL was significantly suppressed in the IMD group compared to the CMC group. IMD‐0354 also tended to suppress the levels of interleukin‐1 beta, tumor necrosis factor‐alpha, and osteoprotegerin. For histological analysis, the relative numbers of TRAP‐positive multinucleated cells decreased significantly in the IMD group compared to the CMC group.
Conclusion
IMD‐0354 regulated bone resorption by ligature‐induced periodontitis, and it is suggested that the inhibition of IKK via down‐regulation of NF kappa‐B may provide periodontal patients with an effective approach to prevent or suppress the disease. |
doi_str_mv | 10.1111/jre.12615 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2117157534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2193987788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5035-6a7be60dc91157e5265062e88dd460aece3aeaec7bc4292f388b0118ba686fae3</originalsourceid><addsrcrecordid>eNp1kM1Kw0AURgdRbK0ufAEZcKOL1PnJTCbLWqpWCoKo2zBJbnTaNKkzidKdj-Az-iSOproQvJuPC-ceLh9Ch5QMqZ-zuYUhZZKKLdSnkpCARFJsoz4hjAU8VGEP7Tk3J36XUbyLepywWHAm-uhhhKv6BUo8XZzjham0A2yqJ5OaprZYNw1UrW7A4dI86qa18PH2bqq8zSDHK7Cmzuuq0SXOjYPuFi9NBvtop9Clg4NNDtD9xeRufBXMbi6n49EsyAThIpA6SkGSPIspFREIJgWRDJTK81ASDRlwDT6iNAtZzAquVEooVamWShYa-ACddN6VrZ9bcE2yNC6DstQV1K1LGKWRNwseevT4DzqvW1v57zwV81hFkVKeOu2ozNbOWSiSlTVLbdcJJclX2YkvO_ku27NHG2ObLiH_JX_a9cBZB7yaEtb_m5Lr20mn_AT504lU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193987788</pqid></control><display><type>article</type><title>A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kure, Keitetsu ; Sato, Hiroki ; Suzuki, Jun‐ichi ; Itai, Akiko ; Aoyama, Norio ; Izumi, Yuichi</creator><creatorcontrib>Kure, Keitetsu ; Sato, Hiroki ; Suzuki, Jun‐ichi ; Itai, Akiko ; Aoyama, Norio ; Izumi, Yuichi</creatorcontrib><description>Backgrounds and Objectives
IMD‐0354 is a novel I kappa‐B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature‐induced periodontitis.
Material and Methods
We ligated around the upper right second molars of 8‐week‐old C57BL/6J mice in the split‐mouth model. The test mice were injected intraperitoneally with IMD‐0354 before the placement of the ligature. The control mice were injected intraperitoneally with 0.5% carboxymethylcellulose (CMC) as vehicle before the placement of the ligature. To determine the optimum concentration of the reagent on ligature‐induced periodontitis in the mice, we examined the effect of three types of concentration, which were 1, 5, and 10 mg/kg of IMD‐0354, as a preliminary experiment. After we determined 10 mg/kg as the optimum concentration for the IMD group by micro‐CT analysis, both the IMD and CMC groups (n = 15 each in total, including all the analyses) were subdivided into two small groups, respectively, for further analyses: I group (unligated side of IMD group), IL group (ligated side of IMD group), C group (unligated side of CMC group) and CL group (ligated side of CMC group). The mice in the IMD and CMC groups were treated with each reagent daily and sacrificed 8 days after the ligation. For assessment of bone resorption, we performed micro‐CT and histological analyses. We also carried out real‐time PCR to investigate proinflammatory and bone metabolic markers.
Results
There were significant differences for linear bone loss and volumetric parameter in the test (IMD) group compared to the control (CMC) group 8 days after ligation. In terms of the mRNA expression level of gingival tissue, the level of RANKL was significantly suppressed in the IMD group compared to the CMC group. IMD‐0354 also tended to suppress the levels of interleukin‐1 beta, tumor necrosis factor‐alpha, and osteoprotegerin. For histological analysis, the relative numbers of TRAP‐positive multinucleated cells decreased significantly in the IMD group compared to the CMC group.
Conclusion
IMD‐0354 regulated bone resorption by ligature‐induced periodontitis, and it is suggested that the inhibition of IKK via down‐regulation of NF kappa‐B may provide periodontal patients with an effective approach to prevent or suppress the disease.</description><identifier>ISSN: 0022-3484</identifier><identifier>EISSN: 1600-0765</identifier><identifier>DOI: 10.1111/jre.12615</identifier><identifier>PMID: 30295325</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Alveolar Bone Loss - diagnostic imaging ; Alveolar Bone Loss - drug therapy ; Alveolar Bone Loss - etiology ; Alveolar Bone Loss - metabolism ; animal model ; Animals ; Benzamides - administration & dosage ; Benzamides - pharmacology ; Bone loss ; Bone resorption ; Carboxymethylcellulose ; Dentistry ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Enzyme inhibitors ; Enzyme Inhibitors - administration & dosage ; Enzyme Inhibitors - pharmacology ; Gene Expression ; Gingiva - metabolism ; Gum disease ; I-kappa B Kinase - antagonists & inhibitors ; IKK inhibitor ; IKK protein ; Inflammation ; Injections, Intraperitoneal ; Interleukin-1beta - metabolism ; Ligation - adverse effects ; Mice, Inbred C57BL ; Molars ; Osteoprotegerin ; Osteoprotegerin - metabolism ; Periodontal diseases ; Periodontitis ; Periodontitis - diagnostic imaging ; Periodontitis - drug therapy ; Periodontitis - etiology ; Periodontitis - metabolism ; RANK Ligand - metabolism ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Teeth ; TRANCE protein ; Tumor Necrosis Factor-alpha - metabolism ; X-Ray Microtomography</subject><ispartof>Journal of periodontal research, 2019-04, Vol.54 (2), p.164-173</ispartof><rights>2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><rights>Copyright © 2019 John Wiley & Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5035-6a7be60dc91157e5265062e88dd460aece3aeaec7bc4292f388b0118ba686fae3</citedby><cites>FETCH-LOGICAL-c5035-6a7be60dc91157e5265062e88dd460aece3aeaec7bc4292f388b0118ba686fae3</cites><orcidid>0000-0003-2623-8255 ; 0000-0003-4716-8532 ; 0000-0001-7689-4440 ; 0000-0001-8959-579X ; 0000-0002-8498-4494</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjre.12615$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjre.12615$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30295325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kure, Keitetsu</creatorcontrib><creatorcontrib>Sato, Hiroki</creatorcontrib><creatorcontrib>Suzuki, Jun‐ichi</creatorcontrib><creatorcontrib>Itai, Akiko</creatorcontrib><creatorcontrib>Aoyama, Norio</creatorcontrib><creatorcontrib>Izumi, Yuichi</creatorcontrib><title>A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice</title><title>Journal of periodontal research</title><addtitle>J Periodontal Res</addtitle><description>Backgrounds and Objectives
IMD‐0354 is a novel I kappa‐B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature‐induced periodontitis.
Material and Methods
We ligated around the upper right second molars of 8‐week‐old C57BL/6J mice in the split‐mouth model. The test mice were injected intraperitoneally with IMD‐0354 before the placement of the ligature. The control mice were injected intraperitoneally with 0.5% carboxymethylcellulose (CMC) as vehicle before the placement of the ligature. To determine the optimum concentration of the reagent on ligature‐induced periodontitis in the mice, we examined the effect of three types of concentration, which were 1, 5, and 10 mg/kg of IMD‐0354, as a preliminary experiment. After we determined 10 mg/kg as the optimum concentration for the IMD group by micro‐CT analysis, both the IMD and CMC groups (n = 15 each in total, including all the analyses) were subdivided into two small groups, respectively, for further analyses: I group (unligated side of IMD group), IL group (ligated side of IMD group), C group (unligated side of CMC group) and CL group (ligated side of CMC group). The mice in the IMD and CMC groups were treated with each reagent daily and sacrificed 8 days after the ligation. For assessment of bone resorption, we performed micro‐CT and histological analyses. We also carried out real‐time PCR to investigate proinflammatory and bone metabolic markers.
Results
There were significant differences for linear bone loss and volumetric parameter in the test (IMD) group compared to the control (CMC) group 8 days after ligation. In terms of the mRNA expression level of gingival tissue, the level of RANKL was significantly suppressed in the IMD group compared to the CMC group. IMD‐0354 also tended to suppress the levels of interleukin‐1 beta, tumor necrosis factor‐alpha, and osteoprotegerin. For histological analysis, the relative numbers of TRAP‐positive multinucleated cells decreased significantly in the IMD group compared to the CMC group.
Conclusion
IMD‐0354 regulated bone resorption by ligature‐induced periodontitis, and it is suggested that the inhibition of IKK via down‐regulation of NF kappa‐B may provide periodontal patients with an effective approach to prevent or suppress the disease.</description><subject>Alveolar Bone Loss - diagnostic imaging</subject><subject>Alveolar Bone Loss - drug therapy</subject><subject>Alveolar Bone Loss - etiology</subject><subject>Alveolar Bone Loss - metabolism</subject><subject>animal model</subject><subject>Animals</subject><subject>Benzamides - administration & dosage</subject><subject>Benzamides - pharmacology</subject><subject>Bone loss</subject><subject>Bone resorption</subject><subject>Carboxymethylcellulose</subject><subject>Dentistry</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme inhibitors</subject><subject>Enzyme Inhibitors - administration & dosage</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression</subject><subject>Gingiva - metabolism</subject><subject>Gum disease</subject><subject>I-kappa B Kinase - antagonists & inhibitors</subject><subject>IKK inhibitor</subject><subject>IKK protein</subject><subject>Inflammation</subject><subject>Injections, Intraperitoneal</subject><subject>Interleukin-1beta - metabolism</subject><subject>Ligation - adverse effects</subject><subject>Mice, Inbred C57BL</subject><subject>Molars</subject><subject>Osteoprotegerin</subject><subject>Osteoprotegerin - metabolism</subject><subject>Periodontal diseases</subject><subject>Periodontitis</subject><subject>Periodontitis - diagnostic imaging</subject><subject>Periodontitis - drug therapy</subject><subject>Periodontitis - etiology</subject><subject>Periodontitis - metabolism</subject><subject>RANK Ligand - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Teeth</subject><subject>TRANCE protein</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>X-Ray Microtomography</subject><issn>0022-3484</issn><issn>1600-0765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Kw0AURgdRbK0ufAEZcKOL1PnJTCbLWqpWCoKo2zBJbnTaNKkzidKdj-Az-iSOproQvJuPC-ceLh9Ch5QMqZ-zuYUhZZKKLdSnkpCARFJsoz4hjAU8VGEP7Tk3J36XUbyLepywWHAm-uhhhKv6BUo8XZzjham0A2yqJ5OaprZYNw1UrW7A4dI86qa18PH2bqq8zSDHK7Cmzuuq0SXOjYPuFi9NBvtop9Clg4NNDtD9xeRufBXMbi6n49EsyAThIpA6SkGSPIspFREIJgWRDJTK81ASDRlwDT6iNAtZzAquVEooVamWShYa-ACddN6VrZ9bcE2yNC6DstQV1K1LGKWRNwseevT4DzqvW1v57zwV81hFkVKeOu2ozNbOWSiSlTVLbdcJJclX2YkvO_ku27NHG2ObLiH_JX_a9cBZB7yaEtb_m5Lr20mn_AT504lU</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Kure, Keitetsu</creator><creator>Sato, Hiroki</creator><creator>Suzuki, Jun‐ichi</creator><creator>Itai, Akiko</creator><creator>Aoyama, Norio</creator><creator>Izumi, Yuichi</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2623-8255</orcidid><orcidid>https://orcid.org/0000-0003-4716-8532</orcidid><orcidid>https://orcid.org/0000-0001-7689-4440</orcidid><orcidid>https://orcid.org/0000-0001-8959-579X</orcidid><orcidid>https://orcid.org/0000-0002-8498-4494</orcidid></search><sort><creationdate>201904</creationdate><title>A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice</title><author>Kure, Keitetsu ; Sato, Hiroki ; Suzuki, Jun‐ichi ; Itai, Akiko ; Aoyama, Norio ; Izumi, Yuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5035-6a7be60dc91157e5265062e88dd460aece3aeaec7bc4292f388b0118ba686fae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alveolar Bone Loss - diagnostic imaging</topic><topic>Alveolar Bone Loss - drug therapy</topic><topic>Alveolar Bone Loss - etiology</topic><topic>Alveolar Bone Loss - metabolism</topic><topic>animal model</topic><topic>Animals</topic><topic>Benzamides - administration & dosage</topic><topic>Benzamides - pharmacology</topic><topic>Bone loss</topic><topic>Bone resorption</topic><topic>Carboxymethylcellulose</topic><topic>Dentistry</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme inhibitors</topic><topic>Enzyme Inhibitors - administration & dosage</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression</topic><topic>Gingiva - metabolism</topic><topic>Gum disease</topic><topic>I-kappa B Kinase - antagonists & inhibitors</topic><topic>IKK inhibitor</topic><topic>IKK protein</topic><topic>Inflammation</topic><topic>Injections, Intraperitoneal</topic><topic>Interleukin-1beta - metabolism</topic><topic>Ligation - adverse effects</topic><topic>Mice, Inbred C57BL</topic><topic>Molars</topic><topic>Osteoprotegerin</topic><topic>Osteoprotegerin - metabolism</topic><topic>Periodontal diseases</topic><topic>Periodontitis</topic><topic>Periodontitis - diagnostic imaging</topic><topic>Periodontitis - drug therapy</topic><topic>Periodontitis - etiology</topic><topic>Periodontitis - metabolism</topic><topic>RANK Ligand - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Teeth</topic><topic>TRANCE protein</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>X-Ray Microtomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kure, Keitetsu</creatorcontrib><creatorcontrib>Sato, Hiroki</creatorcontrib><creatorcontrib>Suzuki, Jun‐ichi</creatorcontrib><creatorcontrib>Itai, Akiko</creatorcontrib><creatorcontrib>Aoyama, Norio</creatorcontrib><creatorcontrib>Izumi, Yuichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of periodontal research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kure, Keitetsu</au><au>Sato, Hiroki</au><au>Suzuki, Jun‐ichi</au><au>Itai, Akiko</au><au>Aoyama, Norio</au><au>Izumi, Yuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice</atitle><jtitle>Journal of periodontal research</jtitle><addtitle>J Periodontal Res</addtitle><date>2019-04</date><risdate>2019</risdate><volume>54</volume><issue>2</issue><spage>164</spage><epage>173</epage><pages>164-173</pages><issn>0022-3484</issn><eissn>1600-0765</eissn><abstract>Backgrounds and Objectives
IMD‐0354 is a novel I kappa‐B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature‐induced periodontitis.
Material and Methods
We ligated around the upper right second molars of 8‐week‐old C57BL/6J mice in the split‐mouth model. The test mice were injected intraperitoneally with IMD‐0354 before the placement of the ligature. The control mice were injected intraperitoneally with 0.5% carboxymethylcellulose (CMC) as vehicle before the placement of the ligature. To determine the optimum concentration of the reagent on ligature‐induced periodontitis in the mice, we examined the effect of three types of concentration, which were 1, 5, and 10 mg/kg of IMD‐0354, as a preliminary experiment. After we determined 10 mg/kg as the optimum concentration for the IMD group by micro‐CT analysis, both the IMD and CMC groups (n = 15 each in total, including all the analyses) were subdivided into two small groups, respectively, for further analyses: I group (unligated side of IMD group), IL group (ligated side of IMD group), C group (unligated side of CMC group) and CL group (ligated side of CMC group). The mice in the IMD and CMC groups were treated with each reagent daily and sacrificed 8 days after the ligation. For assessment of bone resorption, we performed micro‐CT and histological analyses. We also carried out real‐time PCR to investigate proinflammatory and bone metabolic markers.
Results
There were significant differences for linear bone loss and volumetric parameter in the test (IMD) group compared to the control (CMC) group 8 days after ligation. In terms of the mRNA expression level of gingival tissue, the level of RANKL was significantly suppressed in the IMD group compared to the CMC group. IMD‐0354 also tended to suppress the levels of interleukin‐1 beta, tumor necrosis factor‐alpha, and osteoprotegerin. For histological analysis, the relative numbers of TRAP‐positive multinucleated cells decreased significantly in the IMD group compared to the CMC group.
Conclusion
IMD‐0354 regulated bone resorption by ligature‐induced periodontitis, and it is suggested that the inhibition of IKK via down‐regulation of NF kappa‐B may provide periodontal patients with an effective approach to prevent or suppress the disease.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30295325</pmid><doi>10.1111/jre.12615</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-2623-8255</orcidid><orcidid>https://orcid.org/0000-0003-4716-8532</orcidid><orcidid>https://orcid.org/0000-0001-7689-4440</orcidid><orcidid>https://orcid.org/0000-0001-8959-579X</orcidid><orcidid>https://orcid.org/0000-0002-8498-4494</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3484 |
ispartof | Journal of periodontal research, 2019-04, Vol.54 (2), p.164-173 |
issn | 0022-3484 1600-0765 |
language | eng |
recordid | cdi_proquest_miscellaneous_2117157534 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Alveolar Bone Loss - diagnostic imaging Alveolar Bone Loss - drug therapy Alveolar Bone Loss - etiology Alveolar Bone Loss - metabolism animal model Animals Benzamides - administration & dosage Benzamides - pharmacology Bone loss Bone resorption Carboxymethylcellulose Dentistry Disease Models, Animal Dose-Response Relationship, Drug Enzyme inhibitors Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - pharmacology Gene Expression Gingiva - metabolism Gum disease I-kappa B Kinase - antagonists & inhibitors IKK inhibitor IKK protein Inflammation Injections, Intraperitoneal Interleukin-1beta - metabolism Ligation - adverse effects Mice, Inbred C57BL Molars Osteoprotegerin Osteoprotegerin - metabolism Periodontal diseases Periodontitis Periodontitis - diagnostic imaging Periodontitis - drug therapy Periodontitis - etiology Periodontitis - metabolism RANK Ligand - metabolism RNA, Messenger - genetics RNA, Messenger - metabolism Teeth TRANCE protein Tumor Necrosis Factor-alpha - metabolism X-Ray Microtomography |
title | A novel IkB kinase inhibitor attenuates ligature‐induced periodontal disease in mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A30%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20IkB%20kinase%20inhibitor%20attenuates%20ligature%E2%80%90induced%20periodontal%20disease%20in%20mice&rft.jtitle=Journal%20of%20periodontal%20research&rft.au=Kure,%20Keitetsu&rft.date=2019-04&rft.volume=54&rft.issue=2&rft.spage=164&rft.epage=173&rft.pages=164-173&rft.issn=0022-3484&rft.eissn=1600-0765&rft_id=info:doi/10.1111/jre.12615&rft_dat=%3Cproquest_cross%3E2193987788%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193987788&rft_id=info:pmid/30295325&rfr_iscdi=true |